These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 1177315)

  • 1. The quantitative aspects of drug-receptor interactions.
    Levitzki A
    J Mol Biol; 1975 Sep; 97(1):46-53. PubMed ID: 1177315
    [No Abstract]   [Full Text] [Related]  

  • 2. Receptors and acceptors: a necessary distinction in hormone binding studies.
    Birnbaumer L; Pohl SL; Kaumann AJ
    Adv Cyclic Nucleotide Res; 1974; 4(0):239-81. PubMed ID: 4369121
    [No Abstract]   [Full Text] [Related]  

  • 3. The regulatory control of beta-receptor dependent adenylate cyclase.
    Levitzki A; Sevilla N; Steer ML
    J Supramol Struct; 1976; 4(3):405-18. PubMed ID: 1263515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data.
    Kent RS; De Lean A; Lefkowitz RJ
    Mol Pharmacol; 1980 Jan; 17(1):14-23. PubMed ID: 6104284
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular physiology of adrenoreceptors].
    Govyrin VA; Zhorov BS
    Fiziol Zh SSSR Im I M Sechenova; 1984 May; 70(5):529-51. PubMed ID: 6088303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative approach to the comparison of biomolecular topographies.
    Sundaram K; Mahajan S; Mishra RK
    Physiol Chem Phys; 1974; 6(6):469-78. PubMed ID: 4460061
    [No Abstract]   [Full Text] [Related]  

  • 7. Theory of radioimmunoassays and hormone-receptor interactions. II. Simulation of antibody divalency, cooperativity and allosteric effects.
    Rodbard D; Bertino RE
    Adv Exp Med Biol; 1973; 36(0):327-41. PubMed ID: 4369378
    [No Abstract]   [Full Text] [Related]  

  • 8. Distinction between adrenergic and serotonergic receptor subtypes: specificity of drugs and absence of cooperative interactions between adrenergic and serotonergic receptor binding sites.
    Leysen JE; Van Gompel P; Gommeren W
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S78-87. PubMed ID: 2459521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematics of hormone-receptor interaction. I. Basic principles.
    Rodbard D
    Adv Exp Med Biol; 1973; 36(0):289-326. PubMed ID: 4368893
    [No Abstract]   [Full Text] [Related]  

  • 10. Interactions of agonists and antagonists with beta-adrenergic receptors.
    Molinoff PB; Weiland GA; Heidenreich KA; Pittman RN; Minneman KP
    Adv Cyclic Nucleotide Res; 1981; 14():51-67. PubMed ID: 6116391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between bisquaternary ammonium ligands and acetylcholinesterase: complex formation studied by fluorescence quenching.
    Taylor P; Jacobs NM
    Mol Pharmacol; 1974 Jan; 10(1):93-107. PubMed ID: 4846185
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uniqueness of physically reasonable root for the polynomial characterizing the multisite binding model.
    Wang ZX
    Anal Biochem; 1997 Apr; 247(1):177-8. PubMed ID: 9126392
    [No Abstract]   [Full Text] [Related]  

  • 14. Real-time competitive kinetic analysis of interactions between low-molecular-weight ligands in solution and surface-immobilized receptors.
    Karlsson R
    Anal Biochem; 1994 Aug; 221(1):142-51. PubMed ID: 7985785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into signaling from the beta2-adrenergic receptor structure.
    Audet M; Bouvier M
    Nat Chem Biol; 2008 Jul; 4(7):397-403. PubMed ID: 18560432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane receptors and hormone action.
    Cuatrecasas P; Hollenberg MD
    Adv Protein Chem; 1976; 30():251-451. PubMed ID: 180780
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluorescence study of steroid hormone binding activity of Helix pomatia agglutinin.
    Bogoeva VP; Russev GC
    Steroids; 2008 Oct; 73(11):1060-5. PubMed ID: 18501393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Homotropic cooperative effects and rising B-F-curves in hormone-antibody reactions (author's transl)].
    Bartels HJ; Hesch RD
    Z Klin Chem Klin Biochem; 1973 Jul; 11(7):311-8. PubMed ID: 4356285
    [No Abstract]   [Full Text] [Related]  

  • 19. Absolute quantification by positron emission tomography of the endogenous ligand.
    Delforge J; Bottlaender M; Pappata S; Loc'h C; Syrota A
    J Cereb Blood Flow Metab; 2001 May; 21(5):613-30. PubMed ID: 11333372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated beta-adrenergic binding sites: a potential assay vehicle for catecholamines.
    Lefkowitz RJ
    Pharmacol Rev; 1973 Jun; 25(2):259-68. PubMed ID: 4150174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.